Catalyst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2005
Cash & Equivalents	137.64	298.4	171.45	130.25	89.52	16.57	57.51	13.9	31.96	12.82	Upgrade
Short-Term Investments	0	0	19.82	10.04	5.01	36.92	26.52	26.51	26.44	26.46	Upgrade
Cash & Cash Equivalents	137.64	298.4	191.28	140.29	94.53	53.49	84.02	40.41	58.41	39.28	Upgrade
Cash Growth	-53.87%	56.00%	36.35%	48.41%	76.72%	-36.34%	107.90%	-30.80%	48.67%	65.62%	Upgrade
Receivables	53.51	10.44	6.62	5.99	10.54	0	0	0	0	0	Upgrade
Inventory	15.64	6.81	7.87	4.65	1.96	0.06	0	0	0	0	Upgrade
Other Current Assets	12.54	5.17	4.34	8.32	4.34	1.64	1.16	1.04	1.5	4.54	Upgrade
Total Current Assets	219.33	320.81	210.11	159.24	111.36	55.19	85.19	41.45	59.9	43.83	Upgrade
Property, Plant & Equipment	3.7	3.62	3.98	0.13	1	0.25	0.19	0.24	0.19	0.07	Upgrade
Long-Term Investments	16.49	0	0	0	0	5.01	0	0	0	0	Upgrade
Goodwill and Intangibles	194.05	32.47	0	0	0	0	0	0	0	0	Upgrade
Other Long-Term Assets	36.54	18.74	23.71	32.98	0.01	0.01	0.01	0.01	0.01	0.01	Upgrade
Total Long-Term Assets	250.79	54.82	27.68	33.11	1.01	5.26	0.2	0.25	0.2	0.08	Upgrade
Total Assets	470.11	375.63	237.79	192.35	112.38	60.45	85.39	41.71	60.1	43.91	Upgrade
Accounts Payable	14.8	3.98	2.77	4.26	4.12	2.34	1.95	0.93	1.79	1.81	Upgrade
Other Current Liabilities	61.27	53.61	24.3	18.5	19.98	7.17	2.32	1.16	1.65	4.04	Upgrade
Total Current Liabilities	76.06	57.59	27.06	22.76	24.1	9.51	4.27	2.09	3.44	5.86	Upgrade
Long-Term Debt	3.19	3.56	3.89	0	0.65	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	2.98	14.06	0	0	0	0.15	0.16	0.3	1.18	2.81	Upgrade
Total Long-Term Liabilities	6.17	17.62	3.89	0	0.65	0.15	0.16	0.3	1.18	2.81	Upgrade
Total Liabilities	82.23	75.21	30.96	22.76	24.75	9.67	4.42	2.4	4.63	8.67	Upgrade
Total Debt	3.19	3.56	3.89	0	0.65	0	0	0	0	0	Upgrade
Debt Growth	-10.37%	-8.65%	-	-	-	-	-	-	-	-	Upgrade
Retained Earnings	121.27	49.86	-26.31	-53.71	-128.69	-160.56	-126.56	-108.15	-90.08	-69.84	Upgrade
Comprehensive Income	0.01	0.02	-0.15	0.03	0.01	-0.02	0	0	0	0	Upgrade
Shareholders' Equity	387.88	300.42	206.83	169.6	87.63	50.78	80.96	39.31	55.48	35.24	Upgrade
Net Cash / Debt	134.45	294.84	187.38	140.29	93.88	53.49	84.02	40.41	58.41	39.28	Upgrade
Net Cash / Debt Growth	-54.40%	57.35%	33.57%	49.43%	75.51%	-36.34%	107.90%	-30.80%	48.67%	65.62%	Upgrade
Net Cash Per Share	1.18	2.65	1.74	1.32	0.89	0.52	0.98	0.49	0.72	0.61	Upgrade
Working Capital	143.27	263.22	183.04	136.49	87.26	45.68	80.92	39.36	56.46	37.97	Upgrade
Book Value Per Share	3.65	2.91	2.00	1.64	0.85	0.49	0.94	0.47	0.69	0.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).